Centessa Pharmaceuticals nombra a David Grainger, doctor en ciencias naturales y destacado empresario en el campo de la biotecnología, director de innovación
October 06, 2021 19:40 ET
|
Centessa Pharmaceuticals plc
BOSTON y LONDRES, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (la «Sociedad») (Nasdaq: CNTA), una empresa en fase clínica que aprovecha su innovador modelo de negocio centrado en...
Centessa Pharmaceuticals nomina David Grainger, PhD, un importante imprenditore nel campo delle biotecnologie, Chief Innovation Officer
October 06, 2021 19:40 ET
|
Centessa Pharmaceuticals plc
BOSTON e LONDRA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (la "Società") (Nasdaq: CNTA), un'azienda in fase clinica che sfrutta il suo innovativo modello di business incentrato...
Centessa Pharmaceuticals benoemt David Grainger, PhD, een toonaangevende biotechondernemer, tot Chief Innovation Officer
October 06, 2021 19:40 ET
|
Centessa Pharmaceuticals plc
BOSTON en LONDON, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc ("Bedrijf") (Nasdaq: CNTA), een bedrijf in klinische fases dat zijn innovatieve assetgerichte bedrijfsmodel gebruikt...
Centessa Pharmaceuticals anuncia un acuerdo de financiación de 300 millones de dólares con Oberland Capital
October 05, 2021 15:13 ET
|
Centessa Pharmaceuticals plc
~ La nueva línea de crédito de 300 millones de dólares, combinada con el saldo de efectivo de la empresa a 30 de junio de 2021, proporciona acceso a más de 900 millones de dólares para avanzar en los...
Centessa Pharmaceuticals annuncia un accordo di finanziamento da 300 milioni di dollari con Oberland Capital
October 05, 2021 15:13 ET
|
Centessa Pharmaceuticals plc
~ La nuova linea di finanziamento da 300 milioni di dollari, associata al saldo di cassa della Società al 30 giugno 2021, consente l'accesso a oltre 900 milioni di dollari per portare avanti i...
Centessa Pharmaceuticals gibt Abschluss einer Finanzierungsvereinbarung über 300 Millionen USD mit Oberland Capital an
October 05, 2021 15:13 ET
|
Centessa Pharmaceuticals plc
~ Neue 300-Millionen-Dollar-Fazilität bietet in Verbindung mit dem Barbestand des Unternehmens zum 30. Juni 2021 Zugang zu über 900 Millionen USD, mit denen Entwicklungsprogramme vorangetrieben und...
Centessa Pharmaceuticals annonce la signature d'un accord de financement de 300 millions de dollars avec Oberland Capital
October 05, 2021 15:13 ET
|
Centessa Pharmaceuticals plc
~ Une nouvelle facilité de crédit de 300 millions de dollars, combinée au solde de trésorerie de la Société au 30 juin 2021, donne accès à plus de 900 millions de dollars qui permettront la poursuite...
Centessa Pharmaceuticals kondigt financieringsovereenkomst van $ 300 miljoen met Oberland Capital aan
October 05, 2021 15:13 ET
|
Centessa Pharmaceuticals plc
~ Nieuwe faciliteit van $ 300 miljoen, in combinatie met het kassaldo van het bedrijf per 30 juni 2021, biedt toegang tot meer dan $ 900 miljoen om ontwikkelingsprogramma's te stimuleren en...
Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer
October 05, 2021 08:00 ET
|
Centessa Pharmaceuticals plc
BOSTON and LONDON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (“Company”) (Nasdaq: CNTA), a clinical-stage company leveraging its innovative asset-centric business model to...
Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital
October 04, 2021 08:00 ET
|
Centessa Pharmaceuticals plc
BOSTON and LONDON, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (“Centessa” or “Company”) (Nasdaq: CNTA), a clinical-stage company leveraging its innovative asset-centric business...